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Summary
Circadian rhythms are 24-hour oscillations that control a variety of biological processes in living 
systems, including two hallmarks of cancer, cell division and metabolism. Circadian rhythm 
disruption by shift-work is associated with greater risk for cancer development and poor 
prognosis, suggesting a putative tumor suppressive role for circadian rhythm homeostasis. Using a 
genetically-engineered mouse model (GEMM) of lung adenocarcinoma, we have characterized the 
effects of circadian rhythm disruption on lung tumorigenesis. We demonstrate that both 
physiologic perturbation (jet lag) and genetic mutation of the central circadian clock components 
decreased survival and promoted lung tumor growth and progression. The core circadian genes 
Per2 and Bmal1 were shown to have cell-autonomous tumor suppressive roles in transformation 
and lung tumor progression. Loss of the central clock components led to increased c-Myc 
expression, enhanced proliferation and metabolic dysregulation. Our findings demonstrate that 
both systemic and somatic disruption of circadian rhythms contribute to cancer progression.
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Introduction
Lung cancer is the leading cause of cancer deaths worldwide (Siegel et al., 2016). Despite 
the extensive characterization of the somatic events that contribute to tumor initiation and 
progression, little is known about the role of physiologic risk factors, such as circadian 
rhythm disruption by shift-work, in lung tumorigenesis. Epidemiological studies have 
revealed that individuals who work night-shifts are at higher risk for developing cancer 
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(Hansen, 2001; Kloog et al., 2009; Megdal et al., 2005; Schernhammer et al., 2006; 
Schernhammer et al., 2001; Viswanathan et al., 2007) or display poorer cancer prognosis 
(Lis et al., 2003). The mammalian circadian machinery consists of a transcription-translation 
autoregulatory feedback loop composed of the transcriptional activators circadian locomotor 
output cycles kaput (Clock) and aryl hydrocarbon receptor nuclear translocator–like (Arntl, 
also known as Bmal1) and their target genes Period (Per) and Cryptochrome (Cry), which 
rhythmically accumulate and form a repressor complex that interacts with Clock/Bmal1 to 
inhibit their own transcription (Bass and Takahashi, 2010; Sahar and Sassone-Corsi, 2009). 
Systemic and tissue-specific disruption of the circadian machinery leads to changes in 
cellular functions such as cell division and metabolism, both highly relevant to cancer (Bass 
and Takahashi, 2010; Hanahan and Weinberg, 2011; Masri et al., 2016; Sahar and Sassone-
Corsi, 2009). Emerging evidence in several different cellular and in vivo models points to an 
important role of the core circadian genes in carcinogenesis (Filipski et al., 2005; Fu et al., 
2002; Gery et al., 2006; Janich et al., 2011; Kettner et al., 2014; Lee et al., 2010; Puram et 
al., 2016; Sahar and Sassone-Corsi, 2009; Van Dycke et al., 2015; Wood et al., 2008).
Despite several lines of evidence implicating circadian rhythm disruption in cancer, the 
underlying mechanism that contributes to disease development remains elusive. It is unclear 
how oncogenic events may cooperate with circadian clock disruption during cancer initiation 
and progression. Our laboratory has established an autochthonous mouse model of human 
lung adenoma and adenocarcinoma. In these GEMMs, lung tumors are induced in K-
rasLSL-G12D/+;p53flox/flox (KP) or K-rasLSL-G12D/+ (K) mice after intratracheal 
administration of viral vectors expressing Cre-recombinase, which activate a K-rasG12D 
allele alone or concomitantly delete the tumor suppressor p53 in lung epithelial cells 
(Jackson et al., 2005). KRAS and P53 are mutated in 30% and 50% of human lung 
adenocarcinoma patients respectively, making these GEMMs highly relevant to a large 
subset of human lung cancers (Cancer Genome Atlas Research, 2014). In this study we used 
these GEMMs to model circadian rhythm disruption and determined that both genetic and 
physiologic disruption of circadian rhythms promoted lung tumorigenesis.
Results
Physiologic disruption of circadian rhythms by jet-lag accelerates lung tumorigenesis
To investigate the role of circadian rhythm disruption in tumorigenesis, we used pre-clinical 
GEMMs of human lung adenoma and adenocarcinoma. Physiologic disruption of circadian 
rhythm was examined by placing KP animals in normal 12hr light/12hr dark schedule 
(LD12:12) or a previously described jet lag schedule of 8 hours light advance every 2–3 
days, which mimics the circadian disturbance that humans undergo during shift-work (Lee et 
al., 2010; Thaiss et al., 2014). By measuring physical activity, we confirmed that jet lag 
disrupted the circadian behavior of animals (Figure 1a–b); this protocol has been shown to 
disrupt the oscillations of the core circadian genes in multiple tissues (Filipski et al., 2005; 
Lee et al., 2010; Thaiss et al., 2014). Animals were placed in jet lag either a week prior to 
tumor-initiation (jet lag initiation) or 5 weeks after lung tumor initiation (jet lag progression) 
and remained under jet lag conditions until the end of the study 13 weeks post tumor 
initiation (Figure 1c). Animals placed in jet lag during tumor progression for 8-weeks post-
Papagiannakopoulos et al. Page 2
Cell Metab. Author manuscript; available in PMC 2017 August 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
infection had a significant increase in the lung tumor burden (p<0.05; Figure 1d) and a shift 
in the tumor grades, with fewer grade 2 and more grade 3 and 4 tumors (grade 2 p<0.05; 
grade 3 p<0.01; Figure 1e) when compared to LD12:12 animals. Furthermore, animals 
placed in jet lag post-tumor initiation (jet lag progression) conditions showed decreased 
survival (9 days median survival) (p<0.01; Figure 1f). Jet lag starting a week prior to tumor 
initiation (jet lag initiation) led to a modest, but non-significant increase in tumor burden 
(Figure 1d); however, we did observe a significant increase in the percentage of high-grade 
tumors in this cohort compared to LD12:12 animals (grade 3 and 4; p<0.05; Figure 1e). 
Overall, our data demonstrate that physiologic disruption of circadian rhythms by simply 
altering the light cycle accelerates lung tumorigenesis in the context of Kras and p53 
mutations.
Whole-animal loss of Per2 and Bmal1 accelerates lung tumorigenesis
Physiologic disruption of circadian rhythms by jet lag may contribute to enhanced 
tumorigenesis in multiple ways, including effects other hormones, feeding behavior, 
metabolic alterations, inflammation, as well as desynchronization of the circadian 
machinery. To further dissect the role of circadian rhythm disruption in lung tumorigenesis, 
we performed genetic disruption of the circadian machinery by whole-animal clock 
disruption under normal LD12:12 conditions. We used a germline mutant allele of Per2 
(Per2m/m) (Zheng et al., 1999) and generated K; Per2m/m and KP; Per2m/m animals. Upon 
tumor initiation by intratracheal infection with viral Cre, both K (Figure S1A and S1B) and 
KP (Figure 1G and 1H) animals that had systemic Per2 loss-of-function exhibited increased 
tumor burden and grade. Consistent with these findings, both K; Per2m/m (p<0.01; Figure 
S1c) and KP; Per2m/m (p<0.001; Figure 1I) animals also had decreased survival compared to 
wild-type (Per2+/+) controls.
To further validate our finding from the Cre/LoxP-based mouse model, we utilized an 
alternative autochthonous Kras-driven GEMM (KrasLA2/+) that gives rise to sporadic non-
viral induced tumors in various tissues (e.g. lymphoma, papilloma and lung) and 100% 
tumor penetrance in the lung (Johnson et al., 2001). We assessed the effects of systemic 
circadian rhythm disruption by both germline Per2 (Per2m/m) and Bmal1 mutation 
(Bmal1−/−)(Bunger et al., 2000). We observed that both KrasLA2/+; Per2m/m and KrasLA2/+; 
Bmal1−/− animals had an increased lung tumor number (p<0.05 and p<0.01; Figure 1J) and 
exhibited decreased survival (p<0.05 and p<0.01; Figure 1K). We did not observe increased 
tumorigenesis in other sporadic Kras-driven tumors in this model (data not shown). 
Interestingly, KrasLA2/+; Bmal1−/− animals displayed a trend of developing more lung 
tumors and poorer survival than KrasLA2/+; Per2m/m animals, which may be explained by 
Bmal1 loss having a greater impact on circadian rhythm disruption (Bunger et al., 2000; Xu 
et al., 2007; Zheng et al., 1999). These data further support the conclusion that systemic 
circadian rhythm disruption by genetic loss-of-function enhances lung tumorigenesis in two 
independent Kras-driven GEMMs.
Tumor cell-autonomous role of circadian machinery in lung cancer
To assess whether the increase in tumorigenesis upon circadian rhythm disruption could be 
attributed to cancer cell autonomous mechanisms, we utilized a conditional allele of Bmal1 
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(Bmal1flox/flox) (Storch et al., 2007) to delete Bmal1 specifically in cancer cells in the K and 
KP models. Loss of Bmal1 (Bmal1Δ/Δ) in tumors accelerated lung tumor progression in the 
K model (Figure 2A, 2B and 2C). Interestingly however, there was no increase in tumor 
burden in KP tumors with conditional Bmal1 (Bmal1Δ/Δ) loss (Figure S2A), suggesting a 
possible p53-dependent role for Bmal1 as has been suggested by a prior study (Mullenders 
et al., 2009).
To investigate the effects of Per2 loss in KP lung cancer cells growth, we generated multiple 
cell lines from WT and Per2m/m KP tumors of the same histological grade (Figure S2B). KP 
Per2m/m cells proliferated faster and had a greater clonogenic potential compared to WT KP 
cells (Figure S2C and S2D). To ensure that the increased growth of KP Per2m/m tumor-
derived cells lines was not due to strain background, we confirmed the tumor suppressive 
role of Per2 by engineering loss-of-function mutations in Per2 in isogenic C57BL/6 KP 
murine lung cancer cells using CRISPR/Cas9-based editing (Figure S2E). We validated 
Cas9-based cutting and editing at the Per2 locus by immunoblotting and Surveyor assay a 
week after introduction of CRISPR/Cas9 system using three independent sgRNAs against 
Per2 (sgPer2.1, sgPer2.2 and sgPer2.3) or control non-targeting sgRNA (ctrl) (Figure 2D), 
according to standard procedures (Ran et al., 2013; Sanchez-Rivera and Jacks, 2015; Sayin 
and Papagiannakopoulos, 2016). Cells with CRISPR/Cas9-based knockout of Per2 (sgPer2.1 
and sgPer2.3) displayed greater proliferation in low-density culture conditions (Figure 2E, 
2F and 2G) and tumor formation following subcutaneous transplantation in congenic 
immunocompetent C57BL/6 animals (Figure 2H).
Tumor suppressive role of circadian machinery during cellular transformation
To assess whether Per2 loss promotes Kras-driven transformation, we derived mouse 
embryonic fibroblasts (MEFs) from K and KP animals that also harbor mutant (Per2m/m) or 
WT Per2 (Per2+/+). MEFs were infected with adenoviral-Cre to induce the KrasG12D/+ and 
KrasG12D/+; p53−/− mutations. We observed that K and KP Per2m/m MEFs proliferated faster 
than the Per2+/+ controls based on population doublings (Figure S3A and S3B) and EdU 
incorporation (Figure 2I). KP; Per2m/m cells also produced more colonies in low density 
(Figure 2J) and 3D agar (Figure 2K) assays, which assess the ability of cells to proliferate in 
limited paracrine signaling and anchorage-independent conditions, respectively. 
Furthermore, Kras mutant MEFs lacking Per2 function showed increased sensitivity to 
cellular transformation upon overexpression of c-Myc or adenovirus early region 1A (E1A) 
oncogenes compared to Per2+/+, based on low (Figure S3C and S3D) and high density 
(Figure S3F) growth assays as well as 3D agar growth assays (Figure S3E).
Increased proliferation and c-Myc levels in circadian mutants tumors
We next addressed whether the increased tumor burden in the content of circadian gene loss-
of-function was due to increased proliferation. BrdU incorporation analysis revealed 
increased BrdU positive nuclei in K; Per2m/m (p<0.001; Figure 4A), K; Bmal1Δ/Δ tumors 
(p<0.01; Figure 3A) and KP; Per2m/m tumors (p<0.0001; Figure 3B) compared to controls. 
C-Myc function has been shown to be essential for lung tumor growth (Soucek et al., 2013) 
and has been previously implicated in circadian rhythm regulation (Altman et al., 2015; Fu 
et al., 2002; Lee et al., 2010). It has also been demonstrated that the core clock components 
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can negatively regulate c-Myc expression (Fu et al., 2002). Therefore, we assayed the levels 
of c-Myc in autochthonous tumors by immunohistochemistry. As shown in Figure 3, K; 
Per2m/m (p<0.05; Figure 3C and 3F), K; Bmal1Δ/Δ (p<0.01; Figure 3C and 3G) and KP; 
Per2m/m (p<0.0001; Figure 3D and 3I) tumors showed a significant increase in the protein 
levels of c-Myc as compared to control samples K and KP tumors (Figure 3C, 3E and 3H).
Metabolic reprograming of circadian mutant lung cancer cells
Circadian rhythms are known to control a number of metabolic processes, including 
oxidative phosphorylation (Peek et al., 2013), redox homeostasis (Pekovic-Vaughan et al., 
2014) and lipid metabolism (Grimaldi et al., 2010). Recent work has demonstrated that c-
Myc dampens circadian oscillations by opposing BMAL1 transcriptional oscillations and 
disrupting homeostatic glucose and glutamine oscillations (Altman et al., 2015). We 
hypothesized that the increased proliferation of circadian mutant tumor cells may be due to 
upregulated c-Myc driving glycolysis or glutaminolysis. Indeed, KP Per2 mutant cells had 
increased rates of glucose consumption and increased levels of lactate excretion compared to 
Per2+/+ cells (Figure 4A). Furthermore, we observed a significant increase in the levels of 
glutamine consumption in Per2 mutant cells, indicative of increased glutamine usage (Figure 
4B). To determine whether the overall flux of glucose was differentially regulated in Per2 
mutant cells with high levels of c-Myc, we performed tracing of isotope-labeled glucose 
(U-13Cglucose). Increased use of glucose for the TCA cycle was detected as determined by 
carbon 4 labeling (M4) of TCA cycle intermediates (Figure 4C). These data indicate that in 
addition to increased glycolysis by lactate production, there is increased utilization of 
glucose for the TCA cycle in the mitochondria. These data are in agreement with our recent 
findings demonstrating that lung tumors have increased glucose contribution to the TCA 
cycle relative to normal lung tissue (Davidson et al., 2016).
Altered expression of circadian machinery in human lung adenocarcinoma
Our data demonstrates a cell autonomous oncogenic role for circadian rhythm disruption in 
lung tumorigenesis in mouse models of the disease as well as in tissue culture models of 
cellular transformation. We next investigated whether the expression of the core circadian 
pathway genes (PER1, PER2, PER3, CRY1, CRY2, ARNTL and CLOCK) is altered in 
human lung adenocarcinomas. We examined the expression levels of these core circadian 
genes in normal lung samples (n=58) compared to either matched tumors (n=57) or all lung 
adenocarcinomas (n=431) in the TCGA RNAseq expression dataset (Cancer Genome Atlas 
Research, 2014). With the exception of CLOCK, whose expression was significantly 
increased in tumors, the transcripts of all the circadian genes were significantly decreased in 
matched tumors when compared to normal lung (Figure S4A). Furthermore, when we 
subdivided the tumors by grade (T1, T2 and T3) we observed that ARNTL, CRY2 and PER3 
expression decreased significantly in higher grade (T3) compared to lower grade (T1) 
tumors (Figure S4A).
Increased MYC pathway activity in human lung adenocarcinomas with decreased PER2
Finally, we ranked KP lung tumors based on their expression of PER2 and used the top and 
bottom 25% of tumors (n=12) and derived a signature of differential gene expression 
between these sets. Subsequent gene set enrichment analysis (GSEA) of this signature 
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revealed that tumors with low levels of PER2 were enriched in MYC signatures 
(MYC_UP.V1_UP, DANG_MYC_TARGETS_UP), suggesting that tumors with low PER2 
may have increased MYC activity (Figure S4B). These results are consistent with our 
finding in the GEMM that loss of Per2 leads to an increase in c-Myc activity.
Discussion
Circadian rhythm disruption through shift-work has been linked to increased cancer risk in 
multiple types of cancer (Hansen, 2001; Kloog et al., 2009; Schernhammer et al., 2006; 
Schernhammer et al., 2001). The study of physiologic risk factors, such as circadian rhythm 
disruption, has been largely hindered by the lack of rigorous in vivo experimental systems. 
The data presented here demonstrate that circadian rhythm disruption can promote lung 
tumorigenesis and support an important tumor suppressive role for circadian homeostasis. 
Our study illustrates that physiologic or genetic (Bmal1/Per2) circadian can cooperate with 
Kras and p53 to promote lung tumorigenesis. Systemic loss of Per2 and Bmal1 has 
differential effects on circadian behavior of animals (Bunger et al., 2000; Zheng et al., 
1999). Despite these differences on whole-animal behavior, loss of Per2 or Bmal1 
accelerated lung cancer.
Earlier reports using germline mutations in circadian components have highlighted a role for 
circadian rhythm disruption in tumor predisposition (Filipski et al., 2005; Fu et al., 2002; 
Gery et al., 2006; Janich et al., 2011; Kettner et al., 2014; Lee et al., 2010; Sahar and 
Sassone-Corsi, 2009; Van Dycke et al., 2015; Wood et al., 2008). We demonstrate through 
several in vitro and in vivo systems that tumor cell-specific deletion of core clock 
components leads to increased proliferation, c-Myc levels/activation and metabolic activity. 
Our results highlight the importance of cell-autonomous circadian control of fundamental 
cellular processes that are known hallmarks of cancer and promote cellular transformation 
and tumor progression. Our results suggest that increased tumor incidence in circadian 
mutant animals may be a result of tumor cell-autonomous loss of circadian regulation which 
eliminates an additional barrier to transformation and tumor progression. Cell autonomous 
loss of circadian rhythms in human malignancies may occur through both genetic and 
epigenetic mechanisms (Alhopuro et al., 2010; Chen et al., 2005; Kettner et al., 2014; 
Taniguchi et al., 2009). We present evidence for decreased expression of most circadian 
genes in human lung adenocarcinoma patient tumors as compared to matched lung tissue. 
Furthermore, tumors with decreased PER2 gene expression show a significant enrichment in 
c-MYC target expression, further supporting our finding in the GEMMs, where both Per2 
and Bmal1 mutant lung tumors have increased levels of c-Myc. We postulate that as part of a 
homeostatic circadian clock, Per2 and Bmal1 converge in suppressing c-Myc during lung 
tumorigenesis. Therefore loss of Per2 or Bmal1 can independently lead to increased c-Myc 
transcriptional output. Our results are in line with prior studies revealing the competition 
between both Per2 and Bmal1 with oncogenic c-MYC (Altman et al., 2015; Fu et al., 2002; 
Lee et al., 2010). Ebert et al. recently demonstrated that loss of Bmal1 and Clock suppressed 
leukemogenesis, suggesting that circadian disruption can have context specific effects in 
different types of cancers (Puram et al., 2016).
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There are likely many cell-autonomous and non-autonomous mechanisms that are altered in 
response to circadian disruption that can influence tumorigenesis. In this study we developed 
new animal models that enabled us to comprehensively characterize the tumorigenic role of 
systemic and cell-autonomous circadian rhythm disruption. We anticipate our findings will 
provide the critical framework for future research that will further elucidate the mechanisms 
of organismal and cellular control of circadian oscillations on cancer initiation and 
progression.
Experimental Procedures
Animal Experiments
All animal studies were approved by the MIT IACUC. KrasLSL-G12D/+;p53flox/flox (KP), 
KrasLSL-G12D/+ (K) and KrasLA2/+ mice have already been described (DuPage et al., 2009; 
Jackson et al., 2005; Jackson et al., 2001). All animals with circadian mutant alleles were 
maintained on a mixed C57BL/6J x 129SvJ genetic background. For jet lag experiments we 
utilized pure 129SvJ background. We utilized several existing circadian mutant alleles which 
are available from Jackson Laboratories for germline mutant Per2 (Per2tm1Brd/J) (Zheng et 
al., 1999), germline mutant (Arntltm1Bra/J) (Bunger et al., 2000) and conditional 
(Arntltm1Weit/J) (Storch et al., 2007) Bmal1. These mutants were crossed to K, KP or KLA2 
animals. Both male and female mice were infected intratracheally with adenoviruses as 
described (DuPage et al., 2009). Animals were injected intraperitoneally with 30ug of BrdU 
per gram of body weight 4 hours prior to sacrificing animals.
Jet lag conditions and activity monitoring
Randomization was used for mice placed into LD12:12 or jet lag. For jet lag, animals were 
placed in altered light cycle conditions with 8 hours light advance every 2–3 days (Filipski et 
al., 2005; Lee et al., 2010). Jet lag at ‘Initiation’ was performed by placing animals in altered 
light conditions a week before tumor initiation and kept under those conditions for 13 
weeks. For jet lag at ‘Progression’, animals were placed in altered light conditions at five 
weeks post-tumor initiation and kept in jet lag conditions for 8 weeks. Activity monitoring 
of animals was recorded using wireless running wheels and actogram data analysis was 
performed using wheel analysis software (MED associates inc).
Statistics
P-values were determined by Student’s t-test for all measurements of tumor burden and IHC 
quantifications except for contingency tables, in which Fisher’s exact test or Chi-square test 
were used. All error bars denote standard error mean s.e.m.
Additional experimental procedures can be found in the Supplemental Information under 
Supplemental Experimental Procedures
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Physiologic and genetic disruption of circadian rhythms accelerates lung tumorigenesis
Representative double-plotted actogram of KP mice subjected to (A) regular LD12:12 (left) 
and (B) an 8 hour phase advance by Jet lag (right). (C) Schematic of the timeline of 
experiment to assess the effects of jet lag on lung tumorigenesis. Histological assessment of 
lung tumor burden (D) and grade (E) in KP mice placed in normal LD12:12 (n=6) or jet lag 
conditions at initiation (n=7) or tumor progression (n=7). (F) Kaplan-Meier survival analysis 
for KP animals placed in LD12:12 (n=15) or Jet lag initiation (n=13) and progression (n=13) 
conditions. Histological analysis of lung tumor burden (G) and grade (H) in KP mice with 
WT (Per2+/+) (n=12) or germline mutant (Per2m/m) Per2 (n=12). (I) Kaplan-Meier survival 
analysis for KP animals with WT (Per2+/+) (n=10) or mutant (Per2m/m) Per2 (n=5). (J) 
Surface tumor number in KrasLA2/+ WT (+/+) animals (n=12), systemic loss of Per2 
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(Per2m/m) (n=6) and Bmal1 loss (Bmal1−/−) (n=8). (K) Kaplan-Meier survival analysis for 
KrasLA2/+ animals with WT (+/+) (n=50), Per2m/m (n=31) and Bmal1−/− (n=7). Note: n.s. = 
not significant, * = p<0.05, ** = p<0.01, *** = p<0.001, obtained from two-sided Student’s 
t-test. All error bars denote s.e.m.
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Figure 2. Cell autonomous loss of circadian genes enhances transformation and tumorigenesis
(A) Graph of histological assessment of lung tumor burden tumor burden in K animals with 
tumor-specific loss of Bmal1 (Bmal1Δ/Δ) (n=17) compared to WT controls (Bmal1+/+) 
(n=14). Immunohistochemical staining for Bmal1 in Bmal1+/+ (B) and Bmal1Δ/Δ (C) K 
tumors, insets represent high magnification images, scale bar=0.1mm. (D) Western blot 
(WB) and Surveyor analysis of Per2 protein and the Per2 locus, respectively, in KP cell lines 
where Per2 was target by three different short-guide RNAs (sgRNAs) using the CRISPR/
Cas9 system. Representative of three independent replicate low-density clonogenicity assays 
in Ctrl (E), sgPer2.1 (F) and sgPer2.3 (G) targeted KP cells. (H) Tumor volume 
measurements of subcutaneous transplanted CRISPR/Cas9-targeted KP murine lung cancer 
cells. (I) Flow cytometry measurements of EdU incorporation in KP MEFs with WT (+/+) 
or mutant (Per2m/m) Per2. (J) Colony numbers from low-density clonogenicity assays in WT 
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(+/+) or mutant (Per2m/m) Per2 KP cells. (K) Colony numbers from 3D agar assays of WT 
(+/+) or mutant (Per2m/m) Per2 KP cells. All experiments in (E–K) represent data from three 
independent experimental replicates from 3 independent MEF lines. Note: * = p<0.05, ** = 
p<0.01, obtained from two-sided Student’s t-test. All error bars denote s.e.m.
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Figure 3. Enhanced proliferation and increased levels of c-Myc in circadian mutant tumors
Immunohistochemical analysis of BrdU incorporation in tumors from (A) K animals with 
WT (+/+) (n=24), mutant Per2 (Per2m/m) (n=16) and Bmal1 mutant (Bmal1Δ/Δ) (n=16) 
tumors; (B) KP animals with WT (+/+) (n=10), mutant Per2 (Per2m/m) (n=10). 
Immunohistochemical staining of c-Myc (C) K animals with WT (+/+) (n=6), mutant Per2 
(Per2m/m) (n=6) and Bmal1 mutant (Bmal1Δ/Δ) (n=6) tumors; (D) KP animals with WT 
(+/+) (n=10), mutant Per2 (Per2m/m) (n=10). Representative c-Myc immunohistochemical 
images of: K, (E) WT (+/+), (F) Per2 mutant (Per2m/m), (G) Bmal1 mutant (Bmal1Δ/Δ) and 
KP (H) WT (+/+), (I) Per2 mutant (Per2m/m). Scale bars 0.1mm. n= individual tumors. 
Note: * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 obtained from two-sided 
Student’s t-test. All error bars denote s.e.m.
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Figure 4. Altered glucose and glutamine metabolism in circadian mutant cells
Measurements (mg/L per million cells/hour) of (A) glucose consumption and (B) lactate 
excretion, (C) glutamine consumption in KP WT (Per2+/+) or mutant (Per2m/m) cells. (D) 
Percent M4 carbon labeling enrichment in TCA cycle intermediates in in KP WT (Per2+/+) 
or mutant (Per2m/m) cells. Error bars denote standard deviation. Note: * = p<0.05, ** = 
p<0.01, **** = p<0.0001 obtained from two-sided Student’s t-test.
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